A David J. Massop, MD: Efficacy and Safety of Port Delivery System in Portal Extension Trial.

Published Date: 13 Aug 2023

An analysis of the Portal trial, which was presented at ASRS 2023, indicates that in patients with nAMD, the efficacy and safety of PDS with ranibizumab were preserved over a 5-year period.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.

2.

GuCS: Genitourinary Cancers Symposium

3.

Obesity-associated cancers tripled nationwide over past two decades

4.

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

5.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot